News & Updates
Filter by Specialty:
Anaemia in half, iron deficiency in fifth of HK patients with advanced prostate cancer
22 Apr 2025
byNatalia Reoutova
Anaemia affects 52.4 percent, while iron deficiency is present in 20.7 percent of Hong Kong patients with advanced prostate cancer (CaP), according to findings from a local cohort.
Anaemia in half, iron deficiency in fifth of HK patients with advanced prostate cancer
22 Apr 2025
3-year RUBY data support add-on dostarlimab as frontline Tx for endometrial cancer
17 Apr 2025
byAudrey Abella
At the second interim analysis of part 1 of the phase III RUBY study, updated duration of response (DoR) findings suggest that women with primary advanced or recurrent endometrial cancer who have achieved a response with the combination regimen comprising dostarlimab and carboplatin-paclitaxel (CP) have substantially improved DoR.
3-year RUBY data support add-on dostarlimab as frontline Tx for endometrial cancer
17 Apr 2025
Testosterone recovery after ADT tied to improved OS in prostate cancer
16 Apr 2025
byStephen Padilla
Testosterone recovery to a normal level appears predictive of improved overall survival (OS) among men with intermediate-risk prostate cancer who underwent androgen-deprivation therapy (ADT) and radiation therapy (RT), suggests a study.